GC Genome
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
GC Genome provides genomic testing and analysis services, laboratory work that reads a person's DNA to support medical diagnosis, health screening, or research.
Its services are used by healthcare providers, research institutions, and individuals seeking genetic insights. The company is listed on KOSDAQ, South Korea's technology and small-cap stock exchange.
Summary is AI-generated and may contain errors · figures from DART filings
GC Genome in five facts
What does GC Genome do?
GC Genome provides genomic testing and analysis services, laboratory work that reads a person's DNA to support medical diagnosis, health screening, or research.
Where is GC Genome listed and in which sector?
GC Genome (Korean name: 지씨지놈) trades under KRX code 340450 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Industrials sector, Commercial Services.
How large is GC Genome?
Its market capitalisation was US$177.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were GC Genome's latest annual revenue and operating profit?
For fiscal year 2025, GC Genome reported revenue of US$23.8M, operating profit of US$932.6K and net income of US$3.1M, per its annual report on DART (data retrieved from DART on 2026-06-03).
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-06-03
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.